“Saudi Arabia is Secretly Loading Up on THESE 5 Stocks! 🚨”
PFE offers lower valuation and >6% yield; market currently overlooks PFE despite past underperformance.
like Pfizer, for example, which is not only cheaper in price and valuation , but also generates more than 6% as a dividend yield, while Eli Lilly generates less than 1%. I understand that Pfizer's performance was very bad, certainly.
This is the argument that pessimists might make , but I actually think the market is largely overlooking it right now, while I can't say the same about Eli Lilly.